Evidence map›Paper›PMID 40444153›Full record

ReviewFrontiers in cellular and infection microbiology2025

First contact: an interdisciplinary guide into decoding H5N1 influenza virus interactions with glycosaminoglycans in 3D respiratory cell models.

Mariam Hassan, Bianca Kaifer, Tyra Christian, Xenia Tamara Quaas, Johannes Mueller, Heike Boehm

Abstract readReview
In one paragraph

Review in Frontiers in cellular and infection microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Mariam Hassan *Institute of Pharmacy and Molecular Biotechnology, Faculty of Engineering Sciences, Heidelberg University, Heidelberg, Germany.
Bianca Kaifer *Institute of Pharmacy and Molecular Biotechnology, Faculty of Engineering Sciences, Heidelberg University, Heidelberg, Germany.
Tyra Christian *Institute of Pharmacy and Molecular Biotechnology, Faculty of Engineering Sciences, Heidelberg University, Heidelberg, Germany.
Xenia Tamara Quaas *Institute of Pharmacy and Molecular Biotechnology, Faculty of Engineering Sciences, Heidelberg University, Heidelberg, Germany.
Johannes Mueller *Institute of Pharmacy and Molecular Biotechnology, Faculty of Engineering Sciences, Heidelberg University, Heidelberg, Germany.
Heike BoehmMax Planck Institute for Medical Research (MPIMR), Cellular Biophysics, Heidelberg, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The human respiratory system is vulnerable to viral infections. The influenza virus family alone accounts for one billion reported cases annually, some of which are severe and can be fatal. Among these, Influenza A viruses (IAVs) cause the most severe symptoms and course of disease. IAV has been a major health concern, especially since the emergence of the potentially pandemic avian H5N1 strain. However, despite the knowledge that IAVs recognize terminally attached sialic acids on the host cell surface for cell entry, the involvement of other glycans during early infection remains to be elucidated. In particular, the involvement of the alveolar epithelial glycocalyx as a last line of defense is often overlooked. Studying early infection of any virus in real time remains a challenge due to the currently available model systems and imaging techniques. Therefore, we extensively compare the use of different 3D cell systems and provide an overview of currently available scaffold-based and scaffold-free air-liquid interface (ALI) models. In addition, we discuss in detail the preferred use of a recently developed 3D organ tissue equivalent (OTE) model incorporating solubilized extracellular matrix components (sECM) to study viral interaction with glycosaminoglycans (GAGs) during the early stages of IAV infection. We further discuss and recommend the use of various synthetic virus models over IAV virions to reduce complexity by focusing only on surface protein interactions while simultaneously lowering the required biosafety levels, including, but not limited to virus-like particles (VLPs) or DNA origami. Finally, we delve into potential labeling strategies for IAV or IAV-like particles by reviewing internal and external labeling strategies with quantum dots (QDs) and potential GAG labeling, combined with a recommendation to combine high spatial resolution imaging techniques with high temporal resolution tracking, such as single virus tracking.

Indexed as

GlycosaminoglycansHost-Pathogen InteractionsInfluenza A Virus, H5N1 SubtypeAnimalsEpithelial CellsExtracellular MatrixGlycocalyxHumansInfluenza, HumanVirus InternalizationGlycosaminoglycans3D respiratory cell modelsair-liquid Interface (ALI) 3D in vitro modelfluorescent microscopyglycosaminoclycansinfluenza A - subtype H5N1synthetic viruses

Identifiers

PMID40444153
PMCPMC12119590

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.